Andy Sassine - Jun 12, 2024 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role: Chief Financial Officer, Director
Signature: /s/ Ilan Katz, attorney-in-fact
Stock symbol: ARCT
Transactions as of: Jun 12, 2024
Transactions value $: -$1,601,500
Form type: 4
Date filed: 6/14/2024, 04:06 PM
Previous filing: Apr 3, 2024
Next filing: Aug 19, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARCT	Common Stock	Sale	-$1.6M	-50K	-18.48%	$32.03	221K	Jun 12, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 were effected in open market transactions by the Reporting Person.
F2	Reflects the weighted average price of 50,000 shares of common stock of Arcturus Therapeutics Holdings Inc. (the "Issuer") sold by the Reporting Person in multiple transactions on June 12, 2024, with sales prices ranging from $31.52 to $33.54 per share. The Reporting Person undertakes to provide, upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Content

The sales reported on this Form 4 were effected in open market transactions by the Reporting Person.

Reflects the weighted average price of 50,000 shares of common stock of Arcturus Therapeutics Holdings Inc. (the "Issuer") sold by the Reporting Person in multiple transactions on June 12, 2024, with sales prices ranging from $31.52 to $33.54 per share. The Reporting Person undertakes to provide, upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.